Cambridge Healthtech Institute’s 11th Annual

Protocol Development, Global Site Selection, Feasibility and Site Management

Improving Outcomes through Patient-Centric Trial Design, Modeling and Execution

March 2-3, 2021


I am pleased to announce CHI’s 11th Annual Protocol Development, Global Site Selection, Feasibility and Site Management being held March 2-3, 2021 at Rosen Shingle Creek in Orlando, FL. The gathering will be part of the 12th Annual Summit for Clinical Trials Operations Executives (SCOPE), a four-day cluster of events that attracted 2,200 leaders in clinical innovation, operations and research in 2020. Topics to be discussed at the Protocol Development, Global Site Selection, Feasibility and Site Management conference include:


  • The impact of COVID on feasibility and site management
  • Planning and deploying hybrid trials by developing truly patient-centric protocols that enable patient choice
  • Developing protocols for the new post-COVID world: Site-centered, remote and hybrid trials
  • Integrating early patient and site insights in protocol development and site selection
  • Employing trial design and protocol development strategies that support study site compliance: Minimize downstream operational challenges with good design
  • Protocol feasibility and clinical trial simulation: Integrating patient advisors and disease communities into early planning
  • Optimizing country selection: Strategies for positioning trials for success using a global footprint
  • Optimizing the site feasibility process: Improving global site feasibility assessment to identify sites that will recruit on time and within budget
  • Understanding your protocol and its burden on your clin ops teams, sites and patients
  • Objective country feasibility and selection: Where are the patients?
  • Data-driven site selection: Understand the number of sites, their probability of success, and the impact of site non-performance
  • Cost-effective techniques for finding high-performing sites: High-tech and low-tech solutions to avoid uninterested and low enrolling parties
  • Using data science and technology to design and deliver better clinical trials
  • Digitalization of clinical trials and emerging technology that will make a difference in feasibility, study activation and management: Artificial intelligence (AI), machine learning, re-use of health data, mobile tech, wearables
  • Utilizing RWD/RWE and EMRs for protocol feasibility, protocol optimization, recruitment and data-driven trials
  • Re-use of health data to improve study planning and start-up
  • Also, please check out the Participant Engagement Award in honor of Gerald “Jerry” Matczak, the SCOPE Scientific Symposium (SSS), and the Masters in Clinical Research Golf Tournament


If you would like to submit a proposal to give a presentation at this meeting, please click here.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:
Micah Lieberman

Executive Director, Conferences

Cambridge Healthtech Institute (CHI)

Phone: (+1) 541. 482.4709



For partnering and sponsorship information, please contact:

Companies A-O

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.5457



Companies P-Z

Patty Rose Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.1349